In a research report released today, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of MannKind Corporation (NASDAQ:MNKD) and raised the …
In a research report released this morning, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of MannKind Corporation (NASDAQ:MNKD) with a …
Piper Jaffray analyst Joshua Schimmer was out pounding the table on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), reiterating an Overweight rating with a price target of $147, which …
Piper Jaffray analyst Joshua Schimmer was out pounding the table on Inotek Pharmaceuticals Corp (NASDAQ:ITEK) Tuesday, reiterating an Overweight rating and raising the price target from $9 to $29, …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer offered some positive commentary on bluebird bio Inc (NASDAQ:BLUE). The analyst reiterated an …
Piper Jaffray analyst Joshua Schimmer was out pounding the table on Incyte Corporation (NASDAQ:INCY) Friday, reiterating an Overweight rating on the stock and raising the price target …
Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in today with a favorable report on Celgene Corporation (NASDAQ:CELG), raising the price target to $160 (from …
Celgene Corporation (NASDAQ:CELG)’s proposed $7.2 billion acquisition of Receptos Inc (NASDAQ:RCPT) would bring the pharmaceutical giant a potential blockbuster product candidate, Ozanimod, currently in Phase 3 development for the …
In a research report published today, Piper Jaffray analyst Joshua Schimmer offered some favorable commentary on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) after attending a one-day course at …
Piper Jaffray analyst Joshua Schimmer weighed in today with his views on Avalanche Biotechnologies Inc (NASDAQ:AAVL) after the company reported its highly anticipated results of …
